Article Details

Voyager Therapeutics Presents New Preclinical Data Showing Reduction of Pathological Tau with ...

Retrieved on: 2021-05-12 11:26:15

Tags for this article:

Click the tags to see associated articles and topics

Voyager Therapeutics Presents New Preclinical Data Showing Reduction of Pathological Tau with .... View article details on hiswai:

Excerpt

“By directing CNS-targeted AAV vectors to encode a novel anti-tau monoclonal antibody, our approach has the potential to improve the efficacy and ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up